ESR1 and neoplasm: In the univariate analysis by a competing risk model (Table 3), twelve variables (age, race, tumor grade, histology, T-stage, N-stage, radiation, chemotherapy, surgery, ER status, PR status, marital status), the P-value of which presented less than 0.05, were screened for competing risks regression analysis.